Skip To Main Content
 

UNITED STATES RENAL DATA SYSTEM

Home  | About  | Contact

 
Skip Navigation LinksHome > ESRD Quarterly Update - July 2017 - Most Current

Incident and Prevalent counts by quarter
Incident counts of reported ESRD, 2015 Q1 - 2016 Q4
2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4
0 - 19 269 298 270 266 287 266 269 253
20 - 44 3,752 3,626 3,438 3,490 3,724 3,529 3,268 3,377
45 - 64 12,788 12,081 11,419 11,842 12,712 11,875 11,127 11,431
65 - 74 8,446 8,119 7,692 8,091 8,959 8,549 7,938 8,117
75 + 7,572 7,335 6,858 7,103 7,721 7,115 6,640 6,895
Male 19,186 18,331 17,070 17,928 19,485 18,026 16,840 17,469
Female 13,641 13,128 12,607 12,864 13,918 13,308 12,402 12,604
Diabetes 14,975 14,142 13,412 14,467 15,696 14,514 13,412 13,837
Hypertension 9,524 9,091 8,395 8,312 9,196 8,664 8,150 8,257
Glomerulonephritis 2,370 2,416 2,239 2,328 2,500 2,263 2,134 2,080
Cystic kidney 663 692 701 825 914 922 834 794
Other urologic 365 343 333 453 446 447 386 410
Other cause 2,967 2,907 2,894 3,179 3,289 3,251 2,899 2,820
Unknown cause 798 736 635 123 143 112 98 101
Missing cause 1,165 1,132 1,068 1,105 1,219 1,161 1,329 1,774
All 32,827 31,459 29,677 30,792 33,403 31,334 29,242 30,073

^ Data as of March 31, 2017
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2015 Q1 - 2016 Q4
2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4
0 - 19 7,639 7,656 7,610 7,611 7,650 7,649 7,641 7,573
20 - 44 105,782 106,200 106,114 106,072 106,242 106,422 106,197 106,127
45 - 64 304,592 307,161 308,847 310,909 313,263 315,344 316,621 317,587
65 - 74 160,912 163,198 165,664 168,051 170,557 173,366 175,439 177,418
75 + 110,940 112,210 113,703 114,998 115,990 117,240 118,560 119,311
Male 397,582 401,811 405,064 408,672 412,765 416,466 419,160 421,478
Female 292,204 294,537 296,798 298,894 300,862 303,481 305,224 306,464
Unknown 79 77 76 75 75 74 74 74
Diabetes 262,375 265,151 267,455 270,189 273,080 275,858 277,615 278,739
Hypertension 175,924 177,950 179,493 180,751 182,335 184,066 185,452 186,448
Glomerulonephritis 111,651 112,307 112,839 113,343 113,862 114,283 114,576 114,727
Cystic kidney 32,571 32,819 33,067 33,478 33,909 34,365 34,737 35,085
Other urologic 11,363 11,407 11,444 11,558 11,609 11,737 11,791 11,874
Other cause 59,302 59,827 60,309 61,123 61,579 62,255 62,533 62,691
Unknown cause 25,196 25,192 25,144 24,576 24,068 23,641 23,201 22,745
Missing cause 11,483 11,772 12,187 12,623 13,260 13,816 14,553 15,707
All 689,865 696,425 701,938 707,641 713,702 720,021 724,458 728,016

^ Data as of March 31, 2017
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2015 Q1 - 2016 Q4
2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4
White 21,116 20,401 19,376 20,032 21,764 20,327 18,943 19,312
Black/African American 8,578 8,032 7,448 7,851 8,340 7,896 7,181 7,217
Native American/Alaska Native 304 288 271 263 304 319 277 272
Asian 1,294 1,232 1,146 1,203 1,393 1,261 1,172 1,215
Pacific Islander 354 365 372 362 411 395 380 338
Other/Unknown * * . * . * * *
No ME Form 1,179 1,139 1,064 1,076 1,191 1,133 1,286 1,709
Hispanic 4,564 4,405 4,024 4,298 4,794 4,270 3,865 3,992
Non-Hispanic 27,081 25,913 24,589 25,416 27,418 25,929 24,088 24,366
Unknown * * . * . * * *
No ME Form 1,179 1,139 1,064 1,076 1,191 1,133 1,286 1,709
Hemodialysis (%)1 90.75 89.73 89.06 90.14 90.34 89.77 89.17 90.12
CAPD (%)1 4.67 5.38 5.77 5.24 4.68 4.78 5.05 4.51
CCPD (%)1 4.55 4.87 5.15 4.62 4.97 5.42 5.76 5.34
Other (%)1 0.032 0.017 0.021 0.01 0.006 0.024 0.018 0.022
UnKnown (%)1 . . . . . . . .
Cathether Only (%)2 61.87 61.13 61.37 62.78 62.66 62.23 61.73 62.92
Catheter w/ maturing AVF (%)2 17.23 16.64 15.72 15.76 16.1 16.66 15.81 15.72
Catheter w/ maturing AVG (%)2 1.69 1.81 1.82 1.7 1.59 1.65 1.58 1.55
AVF (%)2 16.17 17.23 17.79 16.55 16.6 16.26 17.25 16.69
AVG (%)2 2.80 3.01 3.12 3.01 2.85 3.05 3.38 2.83
Other(%)2 0.2 0.15 0.14 0.14 0.14 0.09 0.17 0.12
Unknown(%)2 0.039 0.026 0.052 0.05 0.063 0.056 0.074 0.16
Pre-ESRD EPO(% Yes)3 13.51 13.6 13.68 13.23 13.27 13.1 13.1 13.12
Pre-ESRD Nephrology(% Yes)3 72.74 73.97 74.54 73.93 74.47 75.48 76.22 75.91
Mean Serum Albumin(g/dL)4 3.16 3.21 3.23 3.19 3.16 3.2 3.22 3.18
Mean Serum Creatinine(mg/dL)4 6.57 6.48 6.48 6.47 6.45 6.43 6.45 6.46
Mean Hemoglobin(g/dL)4 9.4 9.44 9.44 9.36 9.34 9.37 9.39 9.32
All 32,827 31,459 29,677 30,792 33,403 31,334 29,242 30,073
All with ME Form 31,648 30,320 28,613 29,716 32,212 30,201 27,956 28,364
Dialysis Pts with ME Form 31,087 29,692 27,961 29,125 31,686 29,594 27,407 27,868
Hemodialysis Pts w/ ME Form 28,212 26,644 24,903 26,252 28,626 26,567 24,440 25,116

^ Data as of March 31, 2017.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.
Home   |    Contact Us   |    Search
USRDS Coordinating Center | 1415 Washington Heights, Suite 3645 SPH I | Ann Arbor, MI 48109 | 1-888-99USRDS